ABSTRACT

In recent years Dynamic Covalent Chemistry (DCC) has transformed from being an academic curiosity to become an invaluable tool in the creation of functional systems. This contribution examines the role DCC has played over the past decade in Drug Discovery and, in particular, explores the synergy that has become apparent with Fragment Based Lead Discovery.